Cho JY - Search Results

1

Treatment outcome of patients with anaplastic thyroid cancer: a single center experience.

Lim SM, Shin SJ, Chung WY, Park CS, Nam KH, Kang SW, Keum KC, Kim JH, Cho JY, Hong YK, Cho BC. Lim SM, et al. Among authors: cho jy, cho bc. Yonsei Med J. 2012 Mar;53(2):352-7. doi: 10.3349/ymj.2012.53.2.352. Yonsei Med J. 2012. PMID: 22318823 Free PMC article.

2

A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma.

Cho JY, Nam JS, Park MS, Yu JS, Paik YH, Lee SJ, Lee DK, Yoon DS. Cho JY, et al. Yonsei Med J. 2005 Aug 31;46(4):526-31. doi: 10.3349/ymj.2005.46.4.526. Yonsei Med J. 2005. PMID: 16127778 Free PMC article. Clinical Trial.

3

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma.

Cho JY, Paik YH, Chang YS, Lee SJ, Lee DK, Song SY, Chung JB, Park MS, Yu JS, Yoon DS. Cho JY, et al. Cancer. 2005 Dec 15;104(12):2753-8. doi: 10.1002/cncr.21591. Cancer. 2005. PMID: 16294346 Free article. Clinical Trial.

4

Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration.

Roh MR, Cho JY, Lew W. Roh MR, et al. Among authors: cho jy. Yonsei Med J. 2007 Feb 28;48(1):124-6. doi: 10.3349/ymj.2007.48.1.124. Yonsei Med J. 2007. PMID: 17326255 Free PMC article.

5

Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer.

Lim JY, Cho JY, Paik YH, Lee DK, Lee SI, Park HJ, Lee SJ, Lee KS, Yoon DS, Choi SH. Lim JY, et al. Among authors: cho jy. Oncology. 2007;73(1-2):2-8. doi: 10.1159/000120027. Epub 2008 Mar 10. Oncology. 2007. PMID: 18332648 Clinical Trial.

6

Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.

Lim JY, Cho JY, Oh KJ, Choi SH, Lee SI, Jeung HC. Lim JY, et al. Among authors: cho jy. Chemotherapy. 2009;55(4):200-6. doi: 10.1159/000219434. Epub 2009 May 19. Chemotherapy. 2009. PMID: 19451710 Clinical Trial.

7

Outcome of adjuvant therapy for gallbladder cancer.

Park HS, Lim JY, Yoon DS, Park JS, Lee DK, Lee SJ, Choi HJ, Song SY, Lee WJ, Cho JY. Park HS, et al. Among authors: cho jy. Oncology. 2010;79(3-4):168-73. doi: 10.1159/000322914. Epub 2010 Dec 31. Oncology. 2010. PMID: 21212704

8

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH; CLASSIC trial investigators. Bang YJ, et al. Among authors: cho jy. Lancet. 2012 Jan 28;379(9813):315-21. doi: 10.1016/S0140-6736(11)61873-4. Epub 2012 Jan 7. Lancet. 2012. PMID: 22226517 Clinical Trial.

9

Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.

Jeong JH, Lim SM, Yun JY, Rhee GW, Lim JY, Cho JY, Kim YR. Jeong JH, et al. Among authors: cho jy. Oncology. 2012;83(5):292-9. doi: 10.1159/000342376. Epub 2012 Sep 5. Oncology. 2012. PMID: 22964877

10

Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: a subgroup analysis of 3130 cases in a single center.

Lim JY, Hong SW, Lee YS, Kim BW, Park CS, Chang HS, Cho JY. Lim JY, et al. Among authors: cho jy. Thyroid. 2013 Nov;23(11):1423-30. doi: 10.1089/thy.2013.0036. Epub 2013 Sep 27. Thyroid. 2013. PMID: 23496275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,659 results

Search Page

Filters